関連する実験動画
記事DOIの訂正
David Rudilla1,2, Pedro Landete2, Enrique Zamora2
1Air Liquide Healthcare Spain, Spain.
Open respiratory archives
|January 16, 2026
まとめ
本研究は、以前に公開された記事のDOIの誤りを訂正するものです。この訂正により、正確な科学的参照のために研究結果の適切な引用と検索が保証されます。
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosis.
ERJ open research·2026
Same author
SEPAR Position Paper on Infrastructure, Technology, Staffing, Quality Standards, and Management of Intermediate Respiratory Care Units in Spain.
Archivos de bronconeumologia·2026
Same author
[2027: A new year for a new epidemiological study of chronic obstructive pulmonary disease in Spain].
Open respiratory archives·2026
Same author
Ultrasound elastography for pneumothorax diagnosis: beyond the elasto-lung point.
The British journal of radiology·2026
Same author
Evaluating the Swedish translation of the type 1 diabetes specific health-related quality of life questionnaire in young adults.
Frontiers in clinical diabetes and healthcare·2025
Same author
Development of the Breastfed Infant Oral Microbiome Is Associated with Concentrations and Intakes of Human Milk Oligosaccharides.
Nutrients·2025
Same journal
When Pneumonia is not Pneumonia: Pulmonary Venous Thrombosis After Scimitar Syndrome Repair.
Open respiratory archives·2026
Same journal
Building the Future of Interventional Pulmonology: Reflections from the Forum of La Gomera.
Open respiratory archives·2026
Same journal
[Sepsis in the Intermediate Respiratory Care Unit: Restrospective Study].
Open respiratory archives·2026
Same journal
Pulmonary Mass as a Rare Pulmonary Manifestation of Inflammatory Bowel Disease.
Open respiratory archives·2026
Same journal
[BioSAT: Development and conceptual validation of a satisfaction questionnaire regarding biologic therapies for severe asthma through a structured patient-professional co-creation process].
Open respiratory archives·2026
Same journal
Nintedanib in a Dialysis Patient with Idiopathic Pulmonary Fibrosis: A One-Year Follow-Up Without Major Adverse Events.
Open respiratory archives·2026